The ALPL gene makes a protein called alkaline phosphatase, which helps bones and teeth harden properly. This gene helps your body handle key minerals needed for strong bones, steady growth, and normal tooth support. When the ALPL gene does not work well, people may develop hypophosphatasia, a condition that can lead to soft or fragile bones, bone pain, fractures, short stature, or early loss of baby or adult teeth. Effects vary widely, from mild dental problems to more significant bone symptoms.
What is a gene?
Genes are sections of DNA that give your cells instructions for making molecules or directing processes in the body. Some genes hold the information needed to produce proteins, which are the parts of cells that do much of the work. Other genes mainly regulate when certain processes happen, where they take place, and how strongly they occur. As a group, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. To go into this topic in more detail, you can find more in the LearnHub.
Overview
ALPLGene function
What if the gene works
The ALPL gene makes alkaline phosphatase, an enzyme that helps bones and teeth harden normally. It also helps control phosphate, a mineral your body uses to build and maintain these tissues.
Risk
What if the gene does not work
Changes in the ALPL gene can cause hypophosphatasia, which affects bone and tooth mineralization. Milder variants may lead to early tooth loss or stress fractures, while more severe variants can cause soft bones, growth problems, and breathing problems in infancy.
Treatment
What does that mean for your treatment
A confirmed pathogenic variant in the ALPL gene can support use of asfotase alfa, an enzyme replacement used for people with symptomatic hypophosphatasia, especially when onset is in infancy or childhood. Bisphosphonates and similar antiresorptive bone drugs are generally avoided because they can worsen poor bone mineralization.
Conditions associated with ALPL
Gene function
What if the gene works
Much of the ALPL gene's day to day work involves how bones and teeth harden as they grow. Its protein sits on the outer surface of cells and removes phosphate groups from certain molecules. This helps keep the space around cells ready for normal mineral buildup and supports vitamin B6 handling in the body.
The ALPL gene helps clear away pyrophosphate (a substance that slows mineral buildup) around bone cells. This lets calcium and phosphate settle into bone more easily, supporting normal bone strength and growth.
It supports the same mineral building process in teeth, especially in cementum, the layer that helps teeth anchor to the jaw. This steady mineral balance helps teeth develop a firm structure and stable attachment.
The ALPL gene helps convert pyridoxal 5'-phosphate, the active form of vitamin B6, into a form that can move into cells more easily. This supports normal vitamin B6 use in the brain and other tissues.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ALPL gene can make the alkaline phosphatase protein unstable, misshapen, or less able to reach the cell surface, so its activity drops. This helps explain how ALPL gene variants affect enzyme function in hypophosphatasia. Some changes leave partial activity, while more severe variants can leave very little or none. That range often influences whether hypophosphatasia appears earlier and is more marked, or later with milder features.
How variants are linked to conditions
Pathogenic variants in the ALPL gene cause hypophosphatasia, a condition that can affect bones and teeth at any age. The ALPL gene and hypophosphatasia link is well established, with forms ranging from disease recognized before or soon after birth to milder childhood, adult, or tooth-only presentations. Some people mainly have early tooth loss, while others have bone pain, fractures, or growth problems.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply reflect natural variation among people. For many genes, carrying a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ALPL, risk is driven mainly by the specific gene change and whether someone inherits one changed copy or two, so lifestyle does not meaningfully change the chance of having the related condition. Symptom severity can still vary, and some medicines that affect bone, such as bisphosphonates, may worsen problems in people living with ALPL-related disease.
Inheritance of ALPL variants
ALPL-related conditions can be inherited in more than one way, so how ALPL gene variants are inherited depends on the specific condition and variant. Some ALPL variants follow an autosomal dominant pattern, which means a child can inherit the condition from one parent who carries the variant. Other ALPL variants follow an autosomal recessive pattern, which means a child must inherit one altered copy from each parent. In families affected by hypophosphatasia, both inheritance patterns are well recognized.
What does my ALPL result mean for my family?
ALPL changes can run in families, and what this means for relatives depends on the exact form of hypophosphatasia linked to the result. Some ALPL-related forms are passed down in a dominant way, so close relatives may also carry the change and could have symptoms ranging from mild to more noticeable. Other forms are recessive, which means relatives may be healthy carriers without knowing it.
Genetic information
Genetic testing
How you find out about variants
Testing for ALPL gene variants usually uses a blood or saliva sample to read the ALPL gene and look for changes linked to hypophosphatasia. Results may show a disease causing variant, no relevant variant, or a finding that needs more interpretation. This can help confirm or clarify a suspected genetic diagnosis.
When should I consider getting a genetic test?
Consider ALPL genetic testing if you or your child has signs of hypophosphatasia, such as early tooth loss, frequent fractures, bone pain, or a very low alkaline phosphatase blood test. It can also help when this condition runs in the family or when a pregnancy is at risk.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on both the condition and the type of variant involved. Many factors shape how the body works over time, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at the target tissue. This helps explain why the same medication works well for one person, seems weaker in another, or causes more side effects in someone else. These differences are common and are one reason treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way people respond to medications. By studying connections between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the ALPL gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dosing, so it is best to talk with your doctor if you have concerns about a new medicine, side effects, or supplements.
History
ALPL entered medical history through studies of hypophosphatasia, a condition first described in the 1940s in children with unusually soft bones and very low alkaline phosphatase levels. Initially understood only through visible traits, later recognized as tied to a specific gene, the ALPL gene became a key part of explaining why these findings could run in families. In the 1980s, researchers linked the condition to changes in the ALPL gene, which helped connect clinical observations with inherited biology. From these first observations, research expanded steadily. Over time, scientists found that different ALPL variants could be linked to a wide range of effects, from severe forms seen early in life to milder forms recognized in adults. These historical steps shaped today’s understanding of inherited low alkaline phosphatase conditions.